Hospital
Adams County Regional Medical Center
Adams County Regional Medical Center was paid $10.99M by Medicaid between Oct 2019 and Dec 2024, across 208 billing codes. Its largest line is 99284, emergency room visit (serious) — 14% of everything it billed.
33Billing provider infoADAMS COUNTY REGIONAL MEDICAL CENTER
SEAMAN, OH 45679
SEAMAN, OH 45679
33aNPI1851946909assigned 08/06/2019
33bProvider typeCritical Access Hospital
28Total paid$10.99M
24GClaims324,426
24DCodes billed208
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Ohio
Rank by total paid#5 of 26
Median peer was paid$5.33M
This provider vs. median2.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 7,170 | $117K | |
| 2020 | 38,283 | $1.21M | |
| 2021 | 47,605 | $1.38M | |
| 2022 | 41,556 | $1.39M | |
| 2023 | 109,157 | $3.76M | |
| 2024incomplete | 80,655 | $3.12M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 10,928 | 9,887 | $1.49M |
| 96361 | Intravenous infusion, hydration; each additional hour | 13% | 5,288 | 3,972 | $1.44M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 9,684 | 8,948 | $1.26M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.7% | 7,495 | 6,256 | $843K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.5% | 15,174 | 11,983 | $829K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 4.8% | 3,770 | 3,354 | $532K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.1% | 6,252 | 1,727 | $337K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.0% | 1,110 | 916 | $326K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.9% | 1,256 | 1,111 | $318K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2.9% | 1,212 | 739 | $318K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.5% | 824 | 729 | $270K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.0% | 3,114 | 2,327 | $221K |
196 more codes
| 80053 | Comprehensive metabolic panel | 1.8% | 22,412 | $195K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.4% | 1,934 | $159K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.2% | 1,902 | $131K |
| 80061 | Lipid panel | 1.1% | 4,836 | $120K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 4,601 | $118K |
| G0378 | Hospital observation service, per hour | <1% | 1,842 | $105K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 4,411 | $99K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,108 | $98K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 24,899 | $93K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,972 | $89K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 377 | $88K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,266 | $81K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 386 | $74K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 578 | $72K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,723 | $72K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,171 | $66K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,297 | $49K |
| 87631 | <1% | 841 | $48K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,549 | $47K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,958 | $47K |
| 20610 | <1% | 649 | $46K | |
| 11721 | <1% | 3,111 | $46K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 22,904 | $45K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 137 | $34K |
| 97750 | <1% | 405 | $32K | |
| 11056 | <1% | 807 | $30K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,227 | $30K |
| 97162 | <1% | 368 | $26K | |
| 97161 | <1% | 243 | $24K | |
| 71045 | Radiologic examination, chest; single view | <1% | 7,168 | $23K |
| 73630 | <1% | 920 | $22K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 69 | $22K |
| 84439 | <1% | 1,479 | $21K | |
| 72100 | <1% | 409 | $21K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,096 | $18K |
| 97035 | <1% | 384 | $18K | |
| 71250 | <1% | 230 | $17K | |
| 73562 | <1% | 418 | $17K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,449 | $17K |
| 95886 | <1% | 166 | $16K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 370 | $16K |
| 82607 | <1% | 1,230 | $15K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 309 | $15K |
| 73610 | <1% | 487 | $15K | |
| 73030 | <1% | 605 | $14K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 114 | $14K |
| 83615 | <1% | 1,051 | $13K | |
| 97014 | <1% | 451 | $12K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,208 | $11K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 423 | $11K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 962 | $11K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 85 | $11K |
| 73130 | <1% | 431 | $10K | |
| 82746 | <1% | 997 | $10K | |
| 85027 | <1% | 1,371 | $10K | |
| 73564 | <1% | 498 | $10K | |
| 82728 | <1% | 632 | $9K | |
| 84484 | <1% | 5,499 | $8K | |
| 81001 | <1% | 9,156 | $8K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,070 | $7K |
| 74018 | <1% | 160 | $7K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 285 | $7K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 461 | $7K |
| 73110 | <1% | 224 | $6K | |
| 73502 | <1% | 212 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 168 | $6K |
| 83540 | <1% | 590 | $6K | |
| 84153 | <1% | 346 | $5K | |
| 83735 | <1% | 937 | $5K | |
| 86140 | <1% | 637 | $5K | |
| 83550 | <1% | 549 | $5K | |
| 87581 | <1% | 841 | $5K | |
| 87486 | <1% | 841 | $5K | |
| 85610 | <1% | 4,674 | $4K | |
| 72131 | <1% | 45 | $4K | |
| 87186 | <1% | 586 | $4K | |
| 86803 | <1% | 154 | $4K | |
| 83690 | <1% | 8,241 | $4K | |
| 83880 | <1% | 1,277 | $4K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $4K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 359 | $4K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 69 | $4K |
| 85652 | <1% | 621 | $4K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 104 | $4K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 309 | $3K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 16 | $3K |
| 82378 | <1% | 249 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 168 | $3K |
| 82043 | <1% | 413 | $3K | |
| 96376 | <1% | 1,765 | $3K | |
| 82570 | <1% | 321 | $3K | |
| 85730 | <1% | 4,360 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 12 | $3K |
| 93971 | <1% | 28 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 34 | $2K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 501 | $2K |
| J3490 | Unclassified drugs | <1% | 1,442 | $2K |
| 86038 | <1% | 113 | $2K | |
| 93270 | <1% | 41 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,953 | $2K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 54 | $2K |
| 85379 | <1% | 1,188 | $2K | |
| 82803 | <1% | 1,966 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 71 | $2K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 92 | $2K |
| 76642 | <1% | 14 | $2K | |
| 83605 | <1% | 1,632 | $2K | |
| 84550 | <1% | 229 | $2K | |
| 87902 | <1% | 15 | $1K | |
| 96367 | <1% | 382 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 789 | $1K |
| 84145 | <1% | 1,439 | $1K | |
| 93017 | <1% | 18 | $1K | |
| 82550 | <1% | 1,178 | $1K | |
| 87040 | <1% | 1,171 | $1K | |
| 84703 | <1% | 787 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,697 | $996.58 |
| 80076 | <1% | 111 | $974.21 | |
| 86850 | <1% | 34 | $934.05 | |
| 73590 | <1% | 31 | $931.02 | |
| 99217 | <1% | 76 | $889.20 | |
| 72040 | <1% | 13 | $819.36 | |
| 86900 | <1% | 52 | $766.74 | |
| 87070 | <1% | 64 | $743.62 | |
| 99223 | Prolong inpt eval add15 m | <1% | 58 | $702.00 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 31 | $695.37 |
| 97116 | <1% | 30 | $665.36 | |
| 11720 | <1% | 34 | $654.94 | |
| 73080 | <1% | 35 | $586.17 | |
| 84481 | <1% | 51 | $575.00 | |
| 80074 | <1% | 45 | $573.78 | |
| 36600 | <1% | 326 | $572.01 | |
| 83970 | <1% | 33 | $568.74 | |
| 84100 | <1% | 107 | $532.25 | |
| 83026 | <1% | 40 | $503.27 | |
| 80069 | <1% | 57 | $493.62 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,205 | $434.75 |
| 99219 | <1% | 16 | $410.06 | |
| 81025 | <1% | 638 | $356.25 | |
| 84403 | <1% | 30 | $322.40 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 114 | $321.70 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 10,755 | $295.86 |
| 94644 | <1% | 40 | $271.82 | |
| 90715 | <1% | 14 | $260.70 | |
| 87522 | Neg quan hep c or qual rna | <1% | 17 | $224.29 |
| 84156 | <1% | 39 | $214.86 | |
| 0002A | <1% | 64 | $195.79 | |
| 0001A | <1% | 74 | $174.27 | |
| 86901 | <1% | 64 | $152.58 | |
| 82553 | <1% | 133 | $151.66 | |
| 82150 | <1% | 22 | $130.08 | |
| 82565 | <1% | 32 | $123.98 | |
| 82010 | <1% | 134 | $120.80 | |
| 0011A | <1% | 27 | $117.17 | |
| 80051 | <1% | 15 | $114.84 | |
| 51702 | <1% | 107 | $88.22 | |
| 82310 | <1% | 12 | $84.92 | |
| 82784 | <1% | 13 | $67.53 | |
| 84520 | <1% | 16 | $53.38 | |
| 87640 | <1% | 19 | $46.23 | |
| J2704 | Injection, propofol, 10 mg | <1% | 747 | $46.18 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 240 | $43.50 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,198 | $42.52 |
| 0012A | <1% | 34 | $37.98 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 581 | $35.77 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 984 | $34.76 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 819 | $33.44 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 26 | $29.06 |
| J1815 | Injection, insulin, per 5 units | <1% | 27 | $26.46 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 170 | $21.20 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,038 | $17.98 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,829 | $16.51 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 137 | $9.23 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 390 | $9.05 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 111 | $5.90 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 384 | $4.69 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 468 | $2.93 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 858 | $1.52 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 730 | $1.51 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 62 | $0.72 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 413 | $0.62 |
| 80305 | 0% | 252 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 460 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 3,834 | $0.00 |
| 94664 | 0% | 40 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 56 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 17 | $0.00 |
| Q9954 | Oral magnetic resonance contrast agent, per 100 ml | 0% | 103 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 56 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 40 | $0.00 |
| 00731 | 0% | 18 | $0.00 | |
| J1956 | Injection, levofloxacin, 250 mg | 0% | 56 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 192 | $0.00 |
| 99024 | 0% | 57 | $0.00 | |
| 94760 | 0% | 497 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 76 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAGENBACH, PETE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Adams County Hospital | Seaman, OH | $1.70M |
| Adams County Regional Medical Center | West Union, OH | $572K |
| Adams County Regional Medical Center | Georgetown, OH | $458K |
| Adams County Regional Medical Center | Winchester, OH | $276K |
| Adams County Regional Medical Center | Peebles, OH | $162K |
| Adams County Regional Medical Center | Mount Orab, OH | $162K |
| Adams County Hospital | Winchester, OH | $80K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.